Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
115 Cards in this Set
- Front
- Back
Methylphenidate mechanism of action?
|
Increase presynaptic norepinephrine release.
|
|
Methylphenidate uses?
|
ADHD.
|
|
Haloperidol mechanism of action?
|
High potency typical antipsychotic. D2 antagonist; inhibits G(i) thus increases cAMP.
|
|
Haloperidol uses?
|
Schizophrenia, Tourette's syndrome, acute mania, psychosis. Huntington's disease.
|
|
Haloperidol side effects?
|
Neuromalignant syndrome, tardive dyskinesia (extrapyramidal side effect), hyperprolactinemia leading to galactorrhea. Antimuscarinic effects (dry mouth, constipation) and anti-alpha adrenergic effects (hypotension) and anti histamine effects (sedation).
|
|
Trifluoperazine mechanism of action?
|
High potency typical antipsychotic. D2 antagonist; inhibits G(i) thus increases cAMP.
|
|
Trifluoperazine uses?
|
Schizophrenia, Tourette's syndrome, acute mania, psychosis.
|
|
Trifluoperazine side effects?
|
Neuromalignant syndrome, tardive dyskinesia (extrapyramidal side effect), hyperprolactinemia leading to galactorrhea. Antimuscarinic effects (dry mouth, constipation) and anti-alpha adrenergic effects (hypotension) and anti histamine effects (sedation).
|
|
Fluphenazine mechanism of action?
|
High potency typical antipsychotic. D2 antagonist; inhibits G(i) thus increases cAMP.
|
|
Fluphenazine uses?
|
Schizophrenia, Tourette's syndrome, acute mania, psychosis.
|
|
Fluphenazine side effects?
|
Neuromalignant syndrome, tardive dyskinesia (extrapyramidal side effect), hyperprolactinemia leading to galactorrhea. Antimuscarinic effects (dry mouth, constipation) and anti-alpha adrenergic effects (hypotension) and anti histamine effects (sedation).
|
|
Thioridazine mechanism of action?
|
Low potency typical antipsychotic. D2 antagonist; inhibits G(i) thus increases cAMP.
|
|
Thioridazine uses?
|
Schizophrenia, Tourette's syndrome, acute mania, psychosis.
|
|
Thioridazine side effects?
|
RETINITIS PIGMENTOSA. Neuromalignant syndrome, tardive dyskinesia (extrapyramidal side effect), hyperprolactinemia leading to galactorrhea. Antimuscarinic effects (dry mouth, constipation) and anti-alpha adrenergic effects (hypotension) and anti histamine effects (sedation).
|
|
Chlorpromazine mechanism of action?
|
Low potency typical antipsychotic. D2 antagonist; inhibits G(i) thus increases cAMP.
|
|
Chlorpromazine uses?
|
Schizophrenia, Tourette's syndrome, acute mania, psychosis.
|
|
Chlorpromazine side effects?
|
Neuromalignant syndrome, tardive dyskinesia (extrapyramidal side effect), hyperprolactinemia leading to galactorrhea. Antimuscarinic effects (dry mouth, constipation) and anti-alpha adrenergic effects (hypotension) and anti histamine effects (sedation).
|
|
Olanzapine mechanism of action?
|
Atypical antipsychotic. 5-HT2, alpha, H1, and D2 antagonist. Inhibits G(i) and increases cAMP.
|
|
Olanzapine uses?
|
Schizophrenia (both positive and negative symptoms), OCD, anxiety disorder, depression, mania, and Tourette's syndrome.
|
|
Olanzapine side effects?
|
Less EPS and anticholinergic side effects vs typical antipsychotics. Significant weight gain.
|
|
Clozapine mechanism of action?
|
Atypical antipsychotic. 5-HT2, alpha, H1, and D2 antagonist. Inhibits G(i) and increases cAMP.
|
|
Clozapine uses?
|
Schizoprhenia.
|
|
Clozapine side effects?
|
Agranulocytosis (must do weekly WBC monitoring). Less EPS and anticholinergic side effects vs typical antipsychotics. Significant weight gain.
|
|
Quetiapine mechanism of action?
|
Atypical antipsychotic. 5-HT2, alpha, H1, and D2 antagonist. Inhibits G(i) and increases cAMP.
|
|
Quetiapine uses?
|
Schizoprhenia.
|
|
Quetiapine side effects?
|
Less EPS and anticholinergic side effects vs typical antipsychotics.
|
|
Risperidone mechanism of action?
|
Atypical antipsychotic. 5-HT2, alpha, H1, and D2 antagonist. Inhibits G(i) and increases cAMP.
|
|
Risperidone uses?
|
Schizoprhenia.
|
|
Risperidone side effects?
|
Less EPS and anticholinergic side effects vs typical antipsychotics.
|
|
Aripiprazole mechanism of action?
|
Atypical antipsychotic. 5-HT2, alpha, H1, and D2 antagonist. Inhibits G(i) and increases cAMP.
|
|
Aripiprazole uses?
|
Schizoprhenia.
|
|
Aripiprazole side effects?
|
Less EPS and anticholinergic side effects vs typical antipsychotics.
|
|
Ziprasidone mechanism of action?
|
Atypical antipsychotic. 5-HT2, alpha, H1, and D2 antagonist. Inhibits G(i) and increases cAMP.
|
|
Ziprasidone uses?
|
Schizoprhenia.
|
|
Ziprasidone side effects?
|
Less EPS and anticholinergic side effects vs typical antipsychotics.
|
|
Lithium mechanism of action?
|
Inhibits phosphoinositol cascade.
|
|
Lithium uses?
|
Mood stabilizer for bipolar disorder; blocks relapse and acute manic events. Also SIADH.
|
|
Lithium side effects?
|
Tremor, nephrogenic diabetes insipidus, hypothyroidism, teratogenic (Ebstein's abnomality of heart).
|
|
Buspirone mechanism of action?
|
Stimulates 5-HT1A receptors.
|
|
Buspirone uses?
|
Generalized anxiety disorder.
|
|
Buspirone side effects?
|
No sedation, addiction, or tolerence. Does not interact with alcohol.
|
|
Imipramine mechanism of action?
|
TCA; blocks reuptake of norepinephrine and serotonin.
|
|
Imipramine uses?
|
Major depression, bedwetting, fibromyalgia.
|
|
Imipramine side effects?
|
Convusions, coma, respiratory depression and hyperpyrexia. Due to anticholinergic effects. Prolongs QRS thus causes arrhythmias; due to inhibition of voltaged gated sodium channels in the heart. Treat with sodium bicarbonate.
|
|
Amitriptyline mechanism of action?
|
TCA; blocks reuptake of norepinephrine and serotonin.
|
|
Amitriptyline uses?
|
Major depression, fibromyalgia.
|
|
Amitriptyline side effects?
|
SIADH. Convusions, coma, respiratory depression and hyperpyrexia. Due to anticholinergic effects. Prolongs QRS thus causes arrhythmias; due to inhibition of voltaged gated sodium channels in the heart. Treat with sodium bicarbonate.
|
|
Despiramine mechanism of action?
|
TCA; blocks reuptake of norepinephrine and serotonin.
|
|
Despiramine uses?
|
Major depression, fibromyalgia.
|
|
Despiramine side effects?
|
Convusions, coma, respiratory depression and hyperpyrexia. Due to anticholinergic effects. Prolongs QRS thus causes arrhythmias; due to inhibition of voltaged gated sodium channels in the heart. Treat with sodium bicarbonate.
|
|
Nortriptyline mechanism of action?
|
TCA; blocks reuptake of norepinephrine and serotonin.
|
|
Nortriptyline uses?
|
Major depression, fibromyalgia.
|
|
Nortriptyline side effects?
|
Convusions, coma, respiratory depression and hyperpyrexia. Due to anticholinergic effects. Prolongs QRS thus causes arrhythmias; due to inhibition of voltaged gated sodium channels in the heart. Treat with sodium bicarbonate.
|
|
Clomipramine mechanism of action?
|
TCA; blocks reuptake of norepinephrine and serotonin.
|
|
Clomipramine uses?
|
Major depression, OCD, fibromyalgia.
|
|
Clomipramine side effects?
|
Convusions, coma, respiratory depression and hyperpyrexia. Due to anticholinergic effects. Prolongs QRS thus causes arrhythmias; due to inhibition of voltaged gated sodium channels in the heart. Treat with sodium bicarbonate.
|
|
Doxepin mechanism of action?
|
TCA; blocks reuptake of norepinephrine and serotonin.
|
|
Doxepin uses?
|
Major depression, fibromyalgia.
|
|
Doxepin side effects?
|
Convusions, coma, respiratory depression and hyperpyrexia. Due to anticholinergic effects. Prolongs QRS thus causes arrhythmias; due to inhibition of voltaged gated sodium channels in the heart. Treat with sodium bicarbonate.
|
|
Amoxapine mechanism of action?
|
TCA; blocks reuptake of norepinephrine and serotonin.
|
|
Amoxapine uses?
|
Major depression, fibromyalgia.
|
|
Amoxapine side effects?
|
Convusions, coma, respiratory depression and hyperpyrexia. Due to anticholinergic effects. Prolongs QRS thus causes arrhythmias; due to inhibition of voltaged gated sodium channels in the heart. Treat with sodium bicarbonate.
|
|
Fluoxetine mechanism of action?
|
Serotonin-specific reuptake inhibitors.
|
|
Fluoxetine uses?
|
Requires 2-3 weeks to take effect. Depression, OCD< bulimia, social phobias.
|
|
Fluoxetine side effects?
|
Less side effects than TCAs. GI distress, sexual dysfunction (anorgasmia). Serotonin syndrome when combined with MAOIs or other drugs that increase serotonin (tyramine). Treat with cyproheptadine.
|
|
Paroxetine mechanism of action?
|
Serotonin-specific reuptake inhibitors.
|
|
Paroxetine uses?
|
Requires 2-3 weeks to take effect. Depression, OCD< bulimia, social phobias.
|
|
Paroxetine side effects?
|
Less side effects than TCAs. GI distress, sexual dysfunction (anorgasmia). Serotonin syndrome when combined with MAOIs or other drugs that increase serotonin (tyramine). Treat with cyproheptadine.
|
|
Sertraline mechanism of action?
|
Serotonin-specific reuptake inhibitors.
|
|
Sertraline uses?
|
Requires 2-3 weeks to take effect. Depression, OCD< bulimia, social phobias.
|
|
Sertraline side effects?
|
Less side effects than TCAs. GI distress, sexual dysfunction (anorgasmia). Serotonin syndrome when combined with MAOIs or other drugs that increase serotonin (tyramine). Treat with cyproheptadine.
|
|
Citalopram mechanism of action?
|
Serotonin-specific reuptake inhibitors.
|
|
Citalopram uses?
|
Requires 2-3 weeks to take effect. Depression, OCD< bulimia, social phobias.
|
|
Citalopram side effects?
|
Less side effects than TCAs. GI distress, sexual dysfunction (anorgasmia). Serotonin syndrome when combined with MAOIs or other drugs that increase serotonin (tyramine). Treat with cyproheptadine.
|
|
Venlafaxine mechanism of action?
|
SNRIs; inhibits serotonin and norepinephrine reuptake.
|
|
Venlafaxine uses?
|
Depression generalized anxiety disorder.
|
|
Venlafaxine side effects?
|
Increase in blood pressure, stimulant effects, sedation, nausea.
|
|
Duloxetine mechanism of action?
|
SNRIs; inhibits serotonin and norepinephrine reuptake. Stronger NE effect than venlafaxine.
|
|
Duloxetine uses?
|
Depression, diabetic peripheral neuropathy.
|
|
Duloxetine side effects?
|
Increase in blood pressure, stimulant effects, sedation, nausea.
|
|
Phenelzine mechanism of action?
|
Non-selective monoamine oxidase (MAO) inhibitors.
|
|
Phenelzine uses?
|
Atypical depression, anxiety, hypochondriasis.
|
|
Phenelzine side effects?
|
Hypertension with tyramine ingestion (foods like wine and cheese) and beta-agonists. CNS stimulation. Contraindicate with SSRIS or meperidine.
|
|
Tranylcypromine mechanism of action?
|
Non-selective monoamine oxidase (MAO) inhibitors.
|
|
Tranylcypromine uses?
|
Atypical depression, anxiety, hypochondriasis.
|
|
Tranylcypromine side effects?
|
Hypertension with tyramine ingestion (foods like wine and cheese) and beta-agonists. CNS stimulation. Contraindicate with SSRIS or meperidine.
|
|
Isocarboxazid mechanism of action?
|
Non-selective monoamine oxidase (MAO) inhibitors.
|
|
Isocarboxazid uses?
|
Atypical depression, anxiety, hypochondriasis.
|
|
Isocarboxazid side effects?
|
Hypertension with tyramine ingestion (foods like wine and cheese) and beta-agonists. CNS stimulation. Contraindicate with SSRIS or meperidine.
|
|
Bupropion mechanism of action?
|
Increases dopamine and norepinephrine release.
|
|
Bupropion uses?
|
Smoking cessation, atypical antidepressant.
|
|
Bupropion side effects?
|
Stimulant effects (tachycardia, insomnia), headache, seizure in bulimic patients. No sexual side effects. INCREASES SEIZURE THRESHOLD.
|
|
Mirtazapine mechanism of action?
|
alpha-2 adrenergic antagonist (increases release of NE and 5-HT) and potent 5-HT2/3 antagonist.
|
|
Mirtazapine uses?
|
Atypical antidepressant.
|
|
Mirtazapine side effects?
|
Sediation, increased appetite, weight gain, dry mouth.
|
|
Maprotiline mechanism of action?
|
Inhibits norepinephrine reuptake.
|
|
Maprotiline uses?
|
Atypical antidepressant.
|
|
Maprotiline side effects?
|
Sedation, orothostation hypotension.
|
|
Trazodone mechanism of action?
|
Inhibits serotonin reputake.
|
|
Trazodone uses?
|
Atypical antidepressant; typically used for insomnia.
|
|
Trazodone side effects?
|
Priapism, postural hypotension, sediation, nausea.
|
|
Modafinil mechanism of action?
|
Stimulates orexins; increases dopamine, noradrenaline, and serotonin levels.
|
|
Disulfiram mechanism of action?
|
Acetylaldehyde dehydrogenase inhibitor; causes buildup of toxic acetylaldehyde.
|
|
Disulfiram uses?
|
Produces acute sensitivity to alcohol consumption.
|
|
Varenicline mechanism of action?
|
Nicotinic receptor partial agonist.
|
|
Varenicline uses?
|
Smoking cessation.
|
|
Varenicline side effects?
|
Increased risk of suicide, CV disease.
|
|
Naloxone mechanism of action?
|
Opioid antagonist.
|
|
Naloxone uses?
|
Emergency opioid overdose treatment; used IV.
|
|
Naltrexone mechanism of action?
|
Opioid antagonist.
|
|
Naltrexone uses?
|
Dependence treatment, used orally.
|
|
Flumazenil mechanism of action?
|
BDZ antagonist.
|
|
Flumazenil uses?
|
Benzodiazepine overdose; can't be used for barbituate or alcohol overdose.
|
|
Cyproheptadine mechanism of action?
|
5-HT2 antagonist.
|
|
Cyproheptadine uses?
|
Treats serotonin syndrome (hyperthermia, muscle rigidity, CV collapse, flushing, diarrhea, seizures) from the combination of SSRIs and other serotonin increasing drugs (MAOIs).
|